Total Payments
$11,210
2024 Payments
$443.71
Companies
48
Transactions
757
Medicare Patients
13,233
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$11,148 (99.4%)
Education$61.96 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,148 | 754 | 99.4% |
| Education | $61.96 | 3 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,351 | 165 | $0 (2023) |
| Amgen Inc. | $1,301 | 82 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $1,159 | 81 | $0 (2023) |
| Abbott Laboratories | $719.77 | 24 | $0 (2023) |
| Gilead Sciences, Inc. | $676.19 | 57 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $649.55 | 44 | $0 (2023) |
| ABIOMED | $543.33 | 14 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $538.05 | 53 | $0 (2023) |
| Cardiovascular Systems Inc. | $525.11 | 29 | $0 (2023) |
| PFIZER INC. | $405.68 | 25 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $443.71 | 21 | ABIOMED ($123.68) |
| 2023 | $757.58 | 40 | Novartis Pharmaceuticals Corporation ($109.13) |
| 2022 | $1,454 | 94 | Novartis Pharmaceuticals Corporation ($211.40) |
| 2021 | $1,324 | 76 | Cardiovascular Systems Inc. ($260.44) |
| 2020 | $882.27 | 63 | Janssen Pharmaceuticals, Inc ($232.17) |
| 2019 | $2,078 | 177 | Janssen Pharmaceuticals, Inc ($404.95) |
| 2018 | $2,125 | 148 | Janssen Pharmaceuticals, Inc ($330.95) |
| 2017 | $2,146 | 138 | Abbott Laboratories ($373.78) |
All Payment Transactions
757 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ATRICURE, INC. | EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/11/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $30.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/24/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: Not Applicable | ||||||
| 09/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Endocrinology | ||||||
| 09/04/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $20.72 | General |
| Category: Cardiovascular Device | ||||||
| 07/16/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $27.53 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/24/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Renal Denervation System | ||||||
| 06/19/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/04/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 05/21/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Endocrinology | ||||||
| 05/13/2024 | ATRICURE, INC. | SYNERGY ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/07/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Renal Denervation System | ||||||
| 04/18/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $33.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/12/2024 | Philips North America LLC | (5091) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $21.94 | General |
| Category: Medical Device | ||||||
| 04/04/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $31.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/07/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Lithoplasty | ||||||
| 03/04/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Renal Denervation System | ||||||
| 02/29/2024 | Philips North America LLC | (5091) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $21.94 | General |
| Category: Medical Device | ||||||
| 02/13/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Renal Denervation System | ||||||
| 01/30/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Renal Denervation System | ||||||
| 01/26/2024 | Boston Scientific Corporation | Wolverine Coronary Cutting Balloon (Device) | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: Wolverine Coronary Cutting Balloon_IC | ||||||
| 10/12/2023 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $33.00 | General |
| Category: Cardiology | ||||||
| 09/12/2023 | Medtronic, Inc. | ONYX FRONTIER (Device) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Stents | ||||||
| 08/28/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $33.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/26/2023 | Abbott Laboratories | DIAMONDBACK CORONARY (Device) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Vascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,585 | 4,439 | $795,535 | $278,671 |
| 2022 | 35 | 2,848 | 4,605 | $824,084 | $283,026 |
| 2021 | 33 | 3,582 | 5,916 | $1.0M | $355,215 |
| 2020 | 39 | 4,218 | 6,529 | $1.0M | $308,203 |
Total Patients
13,233
Total Services
21,489
Medicare Billing
$1.2M
Procedure Codes
137
All Medicare Procedures & Services
137 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 618 | 1,267 | $235,662 | $106,806 | 45.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 87 | 87 | $91,350 | $27,907 | 30.5% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 113 | 113 | $87,801 | $22,107 | 25.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 159 | 159 | $61,374 | $21,062 | 34.3% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 84 | 166 | $22,576 | $14,641 | 64.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 93 | 94 | $33,746 | $11,901 | 35.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 115 | 179 | $23,091 | $10,792 | 46.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 57 | 228 | $29,412 | $9,952 | 33.8% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 18 | 20 | $25,240 | $8,206 | 32.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 51 | 51 | $14,586 | $5,879 | 40.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 108 | 108 | $41,688 | $5,323 | 12.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 468 | 516 | $24,252 | $5,009 | 20.7% |
| 93459 | Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | Facility | 2023 | 19 | 19 | $18,886 | $4,101 | 21.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 88 | 88 | $16,720 | $4,085 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 56 | $7,061 | $3,374 | 47.8% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 36 | 381 | $11,049 | $3,056 | 27.7% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 43 | 113 | $8,136 | $2,567 | 31.6% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 43 | 113 | $6,554 | $1,847 | 28.2% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 29 | 29 | $3,683 | $1,741 | 47.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 42 | 45 | $3,195 | $1,726 | 54.0% |
| 85610 | Blood test, clotting time | Office | 2023 | 34 | 359 | $5,385 | $1,508 | 28.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 133 | 136 | $9,248 | $1,298 | 14.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 12 | 12 | $2,208 | $1,105 | 50.1% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 16 | 18 | $2,176 | $1,026 | 47.1% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2023 | 16 | 31 | $4,632 | $996.83 | 21.5% |
About Dr. Christopher Smith, M.D
Dr. Christopher Smith, M.D is a Cardiovascular Disease healthcare provider based in Greenville, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1831181486.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Smith, M.D has received a total of $11,210 in payments from pharmaceutical and medical device companies, with $443.71 received in 2024. These payments were reported across 757 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($11,148).
As a Medicare-enrolled provider, Smith has provided services to 13,233 Medicare beneficiaries, totaling 21,489 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 137 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Greenville, SC
- Active Since 08/19/2005
- Last Updated 02/12/2010
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1831181486
Products in Payments
- XARELTO (Drug) $1,373
- ENTRESTO (Drug) $1,040
- Corlanor (Drug) $661.10
- Repatha (Biological) $639.69
- Impella (Device) $543.33
- LifeVest (Device) $538.05
- BRILINTA (Drug) $488.73
- Diamondback Coronary (Device) $453.44
- VERQUVO (Drug) $320.34
- ELIQUIS (Drug) $250.29
- SYNERGY ABLATION SYSTEM (Device) $239.82
- Resolute (Device) $205.92
- PCI Optimization (Device) $175.59
- PRALUENT (Drug) $173.19
- MULTAQ (Drug) $168.84
- JARDIANCE (Drug) $151.73
- VYNDAQEL (Drug) $131.81
- Ultomiris (Drug) $125.00
- Absorb GT1 (Device) $123.47
- Carto 3 System (Device) $121.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Greenville
Dr. Paul Mahoney, Md, MD
Cardiovascular Disease — Payments: $2.0M
Cardiovascular Disease $2.0M
Peter Netzler, M.d, M.D
Cardiovascular Disease — Payments: $299,810
Cardiovascular Disease $299,810
Joseph Manfredi, Md, MD
Cardiovascular Disease — Payments: $287,712
Cardiovascular Disease $287,712
Dr. Gregory Harris, Md, Phd, MD, PHD
Cardiovascular Disease — Payments: $192,161
Cardiovascular Disease $192,161
Dr. Rajasekhar Nekkanti, Md, MD
Cardiovascular Disease — Payments: $124,359
Cardiovascular Disease $124,359
Jeffrey Senfield, Md, MD
Cardiovascular Disease — Payments: $112,019
Cardiovascular Disease $112,019